Status:
COMPLETED
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
Lead Sponsor:
Swedish Orphan Biovitrum
Collaborating Sponsors:
Amgen
Conditions:
Cancer
Lymphoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate whether palifermin (rHuKGF) administered as a single dose is non-inferior to 3 consecutive doses of palifermin in reducing the incidence of severe oral mucositis (World Health Organization...
Eligibility Criteria
Inclusion
- Written informed consent
- Subjects with: non-Hodgkin's lymphoma, Hodgkin's disease, acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, chronic lymphocytic leukemia, or multiple myeloma
- Minimum of 1.5 x 10\^6 CD34+ cells/kg cryopreserved and to be transplanted.
Exclusion
- Cancer other than those specified in inclusion criteria above (except: adequately treated basal cell carcinoma of the skin)
- Prior bone marrow or peripheral blood stem cell transplantation - Negatively selected (purged) stem cell product - Current active infection or oral mucositis
- Congestive heart failure as defined by New York Heart Association class III or IV.
- History of or current diagnosis of pancreatitis
- Inadequate renal function (serum creatinine greater than 1.5x the upper limit of normal per the institutional guidelines)
- Inadequate liver function (direct bilirubin greater than 1.5x the upper limit of normal, aspartate aminotransferase (AST) greater than 3x upper limit of normal and/or alanine aminotransferase (ALT) greater than 3x upper limit of normal per the institutional guidelines)
- Inadequate pulmonary function as measured by a corrected diffusion capacity of carbon monoxide (DLCO) less than 50% of predicted.
- Subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s)
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00109031
Start Date
January 1 2005
End Date
December 1 2010
Last Update
September 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.